SPRB · Spruce Biosciences, Inc. · Executive Compensation
Market Cap
$160.20M
Shares
2.87M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Javier Szwarcberg | M.D., MPH Chief Executive Officer | $2,910,573 |
| Samir Gharib | President and Chief Financial Officer | $1,473,211 |
| Kirk Ways | M.D., Ph.D. Interim Chief Medical Officer | $1,044,412 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Javier Szwarcberg | M.D., MPH Chief Executive Officer | $1,532,187 |
| Ralph William Charlton III | M.D., M.A.S. Former Chief Medical Officer | $1,161,336 |
| Samir Gharib | President and Chief Financial Officer | $929,690 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Javier Szwarcberg | M.D., MPH Chief Executive Officer | $2,157,418 |
| Samir Gharib | President and Chief Financial Officer | $1,201,066 |
| Ralph William Charlton III | M.D., M.A.S. Former Chief Medical Officer | $1,004,904 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Javier Szwarcberg | M.D., MPH Chief Executive Officer | $4,490,855 |
| Samir Gharib | President and Chief Financial Officer | $975,361 |
| Ralph William Charlton III | M.D., M.A.S. Chief Medical Officer | $962,358 |
| Michael Grey | Executive Chairman and Former Interim Chief Executive Officer | $99,700 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Richard King | Former Chief Executive Officer | $5,106,007 |
| Samir Gharib | President and Chief Financial Officer | $2,194,295 |
| Rosh Dias | M.D., M.R.C.P. Former Chief Medical Officer | $1,105,614 |
| Michael Grey | Executive Chairman and Former Interim Chief Executive Officer | $732,303 |
| Ralph William Charlton III | M.D., M.A.S. Chief Medical Officer | — |
| Javier Szwarcberg | M.D., MPH Chief Executive Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Richard King | Former Chief Executive Officer | $2,467,526 |
| Rosh Dias | M.D., M.R.C.P. Former Chief Medical Officer | $1,680,448 |
| Samir Gharib | President and Chief Financial Officer | $793,384 |
| Michael Grey | Executive Chairman and Former Interim Chief Executive Officer | $622,888 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Richard King | Chief Executive Officer | $549,766 |
| Rosh Dias | M.D., M.R.C.P. Chief Medical Officer | — |
| Samir Gharib | Chief Financial Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Adrian Quartel | Chief Medical Officer | Appointed | 2026-07-27 |
| Dale Hooks | Chief Commercial Officer | Appointed | 2026-03-09 |
| Corwin Dale Hooks | Chief Commercial Officer | Appointed | 2026-03-09 |
| Keli Walbert | Class I Director | Appointed | 2025-12-15 |
| Tiba Aynechi | member of the board of directors | Resigned | 2025-12-12 |
| Bali Muralidhar, Ph.D. | member of the Company's board of directors | Resigned | 2025-10-17 |
| Kirk Ways, M.D., Ph.D. | interim Chief Medical Officer | Appointed | 2024-12-27 |
| Ralph William Charlton III, M.D., M.A.S | Chief Medical Officer | Terminated | 2024-12-27 |
Key facts
CIK
1683553
CUSIP
85209E208
13F (30d)
46 filings
46 filers
Visit website
Investor relations